Medicinal Genomics

Going forward, the company will focus on its wholly owned subsidiary Medicinal Genomics Corporation, which conducts cannabis genetics research.

The SBIR Phase 1 award will go toward developing a test using immuno-PCR technology to detect toxins in medical marijuana. 

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Courtagen Life Sciences today said that it has acquired Medicinal Genomics, a Marblehead, Mass.-based firm that has sequenced the genome of Cannabis sativa and Cannabis indica.

By Julia Karow
This article, originally published Jan. 17, has been updated with additional information from Courtagen.

Genetic cancer researcher Constance Griffin has passed away from pancreatic cancer.

Paired Ends

Premium

Kevin McKernan has founded Medicinal Genomics and is also now serving as its CEO. Most recently, he was the head of R&D for Ion Torrent at Life Technologies.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.